- Global Pharma News & Resources

Intravenous Solutions Market surpassed USD 11.3 billion in 2021, owing to increasing incidence of cancer | insightSLICE

The global Intravenous Solutions market size was estimated to be US$ 11.3 billion in 2021 and is expected grow at a CAGR of 7.7% between 2023 to 2032.

When the oral intake of water and food is not feasible owing to a variety of medical disorders or in the event of organ failure, a patient is given intravenous solutions.

Due to an increase in patients with end-stage kidney impairment (ESRD), mouth and esophageal cancer, as well as other related medical problems, there is a growing market for intravenous treatments. Because a patient is unable to take food or water while receiving therapy for these diseases, the nutrients are given to them via intravenous solutions.

Access the sample report:

With 2021 serving as the base year and years from 2022 to 2032 serving as the forecast period, the study titled Intravenous Solutions Market will give Global Market Share Analysis, Trends, and Forecasts.

The report also takes the competitive environment into account, and as a result, it will provide company overviews and market forecasts for the top companies in the Intravenous Solutions Market.

In addition, the study will provide an analysis of the important developments, worldwide and regional sales networks, company strategies, security and exchange overview, R&D activities, manufacturing facilities, market position, staff strength, and key executives for all the leading market participants.

The key players of the Global Intravenous Solutions Market are:

Axa Parenterals Ltd., Amanta Healthcare, Baxter International Inc., B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, JW Life Science, ICU Medical, Inc., Vifor Pharma Management Ltd., and Salius Pharma Private Limited are some of the strong market stakeholders in the global intravenous solutions market.

What is covered in our report for the Intravenous Solutions?

The primary competitive data, including company strategy, product portfolio, significant developments, SWOT analysis, and development and research targets of all the intravenous solutions firms, are taken into account in this study.

Additionally, the market shares of well-known firms operating in the worldwide intravenous solutions market will be calculated. For example, in the case, B. Braun Melsungen Ag generated revenues of US$7462.4 million in 2018.

According to the company’s sector and regional assessment, the B. Braun Hospital Care business division accounted for the majority of the company’s revenue in 2018, with Germany and North America as the two main revenue-producing geographies.

The four business divisions of B. Braun Melsungen Ag are as follows; B. Braun Aesculap, B. Braun OPM, B. Braun Avitum, and B. Braun Hospital Care. The firm’s B. Braun Avitum business segment, which contributed US$1168,8,000,000 in revenue in 2018, provides intravenous solutions in the global market.

Read more about the report inclusions:

The research will also analyze the crucial competitive data, including corporate strategy, product offerings, advancements, SWOT analysis, and all the IV manufacturing companies across the globe.

The participants involved in the market’s distribution chain and value network, as well as their contributions, will be taken into account by the global intravenous solutions market analysis. The product portfolio would include all of the goods in the company’s intravenous solutions market business sector.

Similar to this, the recent developments section will concentrate on a company’s most recent activities, including mergers and acquisitions, strategic alliances and collaborations, the launch of new products, and geographic expansion in the IV solutions industry.

What is the regional growth forecast for the global intravenous solutions market?

The market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South America depending on location. Over 500,000 individuals got dialysis therapy in the United States in 2016, and the National Kidney Foundation estimates that 15% of adult Americans have chronic kidney problems.

The need for intravenous solutions is expected to increase over the next few years due to the rising number of patients with kidney failure internationally.

The average lifespan of the elderly population has also increased due to the growing geriatric population and better healthcare services. Asia Pacific is therefore anticipated to experience the largest growth during the projection period.

Related reports:

Global Subcutaneous Drug Delivery Devices Market:

Global Legal Marijuana Market:

Global Intravenous Solutions Market Key Segments:

Based On Solution Type

  • Saline
  • Dextran
  • Lactated Ringer’s
  • Amino Acid
  • Vitamins & Minerals
  • Heparin And Trace Elements
  • Mixed Solutions

Based On Bag Capacity

  • Small Volume Bags (Less Than 250ml)
  • Large Volume Bags (Greater Than 250 Ml)

Based On Application

  • Basic Intravenous Solution
  • Nutritional Intravenous Solution
  • Blood Intravenous Solution
  • Drug Intravenous Solution
  • Irrigation Intravenous Solution

Based On End User

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Home Care Settings

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 28-Nov-2022